HIGHLIGHTS
- who: Tineke Casneuf from the Levine Cancer Institute/Carolinas Healthcare System, Charlotte, NC, USA have published the research work: Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab, in the Journal: (JOURNAL)
- what: This study was conducted according to the Declaration of Helsinki and the International Conference on Harmonization Good Clinical Practice guidelines, study protocols and analysis plans were approved by ethics committees or institutional review boards at each study site, and all patients provided written informed consent. Nodes are colored by decrease (cyan; green, if significant ) or increase (magenta . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.